Acurx Pharmaceuticals, Inc. (ACXP) stock

ACXPNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30

$0.96−0.03 (-2.54%)

Close on Nov 13, 2026Market cap $5.06MP/E –Yield –

Acurx Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

Acurx Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?